Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Multiple Sclerosis
100%
Progressive multiple Sclerosis
12%
Multiple Sclerosis Treatment
11%
Cardiac Magnetic Resonance Imaging (cMRI)
11%
Diffusion Tensor Imaging
11%
Relapsing-remitting multiple Sclerosis
11%
Disability
9%
Radial Diffusivity
9%
Neuromyelitis Optica
9%
Optic Neuritis
9%
Diffusion Spectrum Imaging
8%
Dimethyl Fumarate
8%
Ibudilast
7%
Cerebrospinal Fluid
7%
Optic Nerve
6%
Diroximel Fumarate
6%
Demyelination
5%
Disease-modifying Therapy
5%
Placebo
5%
95% Confidence Interval
5%
Phase II Trial
5%
Healthcare Solutions
5%
Advanced Technologies
5%
Ocrelizumab
5%
Optical Coherence Tomography
5%
Control Phase
5%
Randomized Double-blind
5%
Multiple Sclerosis Diagnosis
5%
Technology Solutions
5%
Brain Atrophy
5%
Neuroscience
Multiple Sclerosis
75%
Magnetic Resonance Imaging
18%
Diffusion Tensor Imaging
10%
Optic Neuritis
9%
Spinal Cord
7%
Neuromyelitis Optica
7%
Placebo
6%
Optic Nerve
6%
Biological Marker
5%